U.S. Physical Therapy appoints Myra Davis. U.S. Physical Therapy stock costs EUR 75.75

Published on 10/15/2026 at 13:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Myra Davis joined the board on October 1, 2026, after a September 21 announcement. U.S. Physical Therapy stock costs EUR 75.75 on October 15, 2026.

Board appointment and earnings dates

Myra Davis took her board seat on October 1, 2026, after the September 21 announcement.
Second-quarter revenue reached USD 214.06 million, up 8.50 percent year over year.
U.S. Physical Therapy stock trades at EUR 75.75 at 1:02 p.m. CEST at Lang & Schwarz on October 15, 2026.

USPH, US90337L1089, Illustration mit AI erstellt.

U.S. Physical Therapy (ISIN US90337L1089) was trading at EUR 75.75 at Lang & Schwarz on October 15, 2026, at 1:02 p.m. CEST. The company had appointed Myra Davis to its board effective October 1, according to Fidelity on September 21, 2026.

Technology expertise joins the board

Davis is executive vice president and chief information innovation officer at Texas Children's Hospital, where she has worked in information technology roles since 2003. She also serves on the board of Werfen. Her appointment adds a technology and innovation background to a healthcare-services company that owns or manages 799 outpatient physical therapy clinics in 45 states, according to the same company announcement carried by Fidelity.

What does second-quarter growth leave to watch?

U.S. Physical Therapy reported USD 214.06 million of revenue for the second quarter of 2026, an 8.50 percent increase from the year-earlier quarter. The result came with adjusted EBITDA of USD 27.00 million, compared with USD 26.90 million a year earlier, while the adjusted physical therapy gross profit margin contracted to 19.90 percent from 21.40 percent, according to ScanX on September 18, 2026.

The margin comparison is the more important operating signal than revenue growth alone. ScanX reported that higher self-insured healthcare costs and upfront hiring for hospital affiliations offset volume gains. The company also reaffirmed adjusted EBITDA guidance of USD 102 million to USD 106 million for fiscal year 2026.

Next reporting dates are set

MarketBeat lists November 4, 2026, as the estimated date for third-quarter 2026 results, followed by the earnings call on November 5, 2026, at 10:30 a.m. ET. Its consensus calls for USD 214.48 million in revenue and adjusted earnings per share of USD 0.7610 for that quarter.

Stock price and operating scale

At Lang & Schwarz, U.S. Physical Therapy stock was trading at EUR 75.75 on October 15, 2026, at 1:02 p.m. CEST. The primary listing is on the NYSE, where the quoted 52-week range was USD 58.19 to USD 93.50 as of October 14, 2026, and market capitalization was USD 1.3 billion.

The further course of trading is shown by the continuously updated real-time quote of U.S. Physical Therapy stock.